DOUBLEBITE
Dead / Abandoned — Abandoned — failure to respond (as of 27 Dec 2021)
What this means for you
This application is over — abandoned 09 Nov 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90222015
- Mark type
- Stylized text
- Filed
- 29 Sept 2020
- Abandoned
- 09 Nov 2021
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; drug development and discovery services; scientific and technological services, namely, research and design in the field of drug development for the treatment of cancer; clinical test data analysis services; pharmaceutical testing and clinical trials services; scientific and technological services in the field of pharmaceuticals and biotechnology, namely, research and development in immunology and cancer treatment
Owner
- Innovative Cellular Therapeutics, Inc, Rockville, MD, US
Prosecution history
- 28 Feb 2023 — AMENDMENT CORRESPONDENCE ENTERED
- 28 Dec 2021 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 27 Dec 2021 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 06 May 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 May 2021 — NON-FINAL ACTION E-MAILED
- 06 May 2021 — NON-FINAL ACTION WRITTEN
- 26 Apr 2021 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 23 Mar 2021 — WITHDRAWN FROM PUB - OG REVIEW QUERY
- 08 Mar 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Mar 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Mar 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Mar 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 01 Mar 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 01 Mar 2021 — NON-FINAL ACTION E-MAILED
- 01 Mar 2021 — NON-FINAL ACTION WRITTEN